Collegium Pharmaceutical, Inc. Payments to Acquire Businesses, Gross
Collegium Pharmaceutical, Inc. (COLL) reported Payments to Acquire Businesses, Gross of $18.88 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2018-11-08
- Collegium Pharmaceutical, Inc. payments to acquire businesses, gross for the quarter ending 2018-09-30 was $0.00.
- Collegium Pharmaceutical, Inc. payments to acquire businesses, gross for the quarter ending 2018-06-30 was $116.00K.
- Collegium Pharmaceutical, Inc. payments to acquire businesses, gross for the quarter ending 2018-03-31 was $18.76M.
| Period end | Payments to Acquire Businesses, Gross 3 month | Payments to Acquire Businesses, Gross 6 month | Payments to Acquire Businesses, Gross 9 month |
|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $116.00K derived: sum of 2 quarters · filed 2018-11-08 | $18.88M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $18.88M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $18.76M 10-Q · filed 2018-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |